You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 31 - 40 of 1616 results
 
  • Record 1 TO 1000
  • Record 1001 TO 1616

  1. Study of CdZnTe Electrode Interface and Fabrication Technology Development

    SBC: Aguila Technologies, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): In several recent PA's, the NIH has articulated a clear vision for the future of medical imaging systems a) enhanced spatial or temporal resolution, b) better sensitivity and specificity, c) multi-modality, and d) new functional or molecular imaging or spectroscopy methods. Owing to their unique combination of properties, direct conversion gamma radiation imagi ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health

  2. Study of CdZnTe Electrode Interface and Fabrication Technology Development

    SBC: Aguila Technologies, Inc.            Topic: N/A

    Not avaiable.

    STTR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health

  3. CODA Assembly of Mutant Genes

    SBC: VERDEZYNE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The general goal of this proposal is to assemble directed mutant gene sets quickly, cheaply, easily, and reliably. Mutant gene sets can share sub-assemblies, yielding savings of time, cost, and effort not possible if designed and assembled all as single genes. The approach is to build upon experience gained in Phase I, to extend and generalize methods of DNA de ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health

  4. Oral Formulation of Zonulin Antagonist AT-1001 for Diabe

    SBC: ALBA THERAPEUTICS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): The trigger for autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D) is unclear. Evidence exists for the role of increased intestinal permeability, secondary to intestinal tight junctions (tj) disassembly, in the pathogenesis of various autoimmune diseases including T1 D. Over the last decade our studies have focused on the mechanism(s) of a ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health

  5. MRI with Protease-Sensing Contrast Agents

    SBC: ALERION BIOMEDICAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to design, synthesize, and test a new class of biochemically activated magnetic resonance imaging (MRI) contrast agents to detect and monitor enzymatic activity in vivo. The proposal responds to the Program Announcement entitled "Systems and methods for small animal imaging". We base this work on the hypothesis that a ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  6. N/A

    SBC: Alliance Pharmaceutical Corp.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  7. N/A

    SBC: Alliance Pharmaceutical Corp.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  8. N/A

    SBC: Alliance Pharmaceutical Corp.            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  9. IMPROVED METHOD OF ISOLATION AND GROWTH OF H PYLORI

    SBC: Alliance Pharmaceutical Corp.            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services

  10. GENETIC IMMUNIZATION OF NEONATES AGAINST INFLUENZA VIRUS

    SBC: Alliance Pharmaceutical Corp.            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services
US Flag An Official Website of the United States Government